Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-29 @ 2:37 PM
Study NCT ID:
NCT01564251
Status:
COMPLETED
Last Update Posted:
2020-02-25
First Post:
2012-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-23
First Submit QC Date:
None
Study First Post Date:
2012-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-22
Last Update Post Date:
2020-02-25
Last Update Post Date Type:
ACTUAL